Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations

Autor: Jonathan P. Roiser, A. Frajerman, Philippe Nuss, Kim Sweers, Nathanael Lapidus, Florian Ferreri, Catherine Delva, Haifa Bergaoui, Cedric Tessier, M. De Hert, Antonin Lamaziere
Přispěvatelé: Laboratoire des biomolécules (LBM UMR 7203), Chimie Moléculaire de Paris Centre (FR 2769), École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Institut de Chimie du CNRS (INC)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS-PSL), Université Paris sciences et lettres (PSL)-Institut de Chimie du CNRS (INC)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Département de Chimie - ENS Paris, Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Sylia Stat Lancrenon S.A.S., Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie - Paris 6 (UPMC), Institute of Cognitive Neuroscience (ICN-UCL), University College of London [London] (UCL), INSERM-ERL 1157, CHU St Antoine, UPC-KU Leuven, Service de santé publique [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), HAL-UPMC, Gestionnaire
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
Erythrocytes
Dopamine
Statistics as Topic
[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health
Neuropsychological Tests
Synaptic Transmission
0302 clinical medicine
Wisconsin Card Sorting Test
Phospholipids
Positive and Negative Syndrome Scale
Fatty Acids
Middle Aged
Sphingomyelins
3. Good health
Psychiatry and Mental health
Female
Schizophrenic Psychology
Original Article
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Psychopharmacology
Sphingomyelin
Psychology
Signal Transduction
Psychopathology
medicine.drug
Clinical psychology
Adult
medicine.medical_specialty
Psychometrics
Membrane Lipids
03 medical and health sciences
Cellular and Molecular Neuroscience
Internal medicine
medicine
Humans
Dementia
Cognitive Dysfunction
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Biological Psychiatry
Case-control study
Lipid Metabolism
medicine.disease
030227 psychiatry
Endocrinology
Case-Control Studies
[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental health
Chronic Disease
Schizophrenia
030217 neurology & neurosurgery
Zdroj: Translational Psychiatry
Translational Psychiatry, 2016, 6 (10), pp.e906. ⟨10.1038/tp.2016.142⟩
Translational Psychiatry, Nature Pub. Group, 2016, 6 (10), pp.e906. ⟨10.1038/tp.2016.142⟩
Europe PubMed Central
ISSN: 2158-3188
DOI: 10.1038/tp.2016.142⟩
Popis: Schizophrenia is a severe mental condition in which several lipid abnormalities—either structural or metabolic—have been described. We tested the hypothesis that an abnormality in membrane lipid composition may contribute to aberrant dopamine signaling, and thereby symptoms and cognitive impairment, in schizophrenia (SCZ) patients. Antipsychotic-medicated and clinically stable SCZ outpatients (n=74) were compared with matched healthy subjects (HC, n=40). A lipidomic analysis was performed in red blood cell (RBC) membranes examining the major phospholipid (PL) classes and their associated fatty acids (FAs). Clinical manifestations were examined using the positive and negative syndrome scale (PANSS). Cognitive function was assessed using the Continuous Performance Test, Salience Attribution Test and Wisconsin Card Sorting Test. Sphingomyelin (SM) percentage was the lipid abnormality most robustly associated with a schizophrenia diagnosis. Two groups of patients were defined. The first group (SCZ c/SM−) is characterized by a low SM membrane content. In this group, all other PL classes, plasmalogen and key polyunsaturated FAs known to be involved in brain function, were significantly modified, identifying a very specific membrane lipid cluster. The second patient group (SCZ c/SM+) was similar to HCs in terms of RBC membrane SM composition. Compared with SCZ c/SM+, SCZ c/SM− patients were characterized by significantly more severe PANSS total, positive, disorganized/cognitive and excited psychopathology. Cognitive performance was also significantly poorer in this subgroup. These data show that a specific RBC membrane lipid cluster is associated with clinical and cognitive manifestations of dopamine dysfunction in schizophrenia patients. We speculate that this membrane lipid abnormality influences presynaptic dopamine signaling.
Databáze: OpenAIRE